Deterioration of vascular reactivity has pivotal role in diabetic vascular complications. Apigenin is a natural flavonoid with protein kinase C inhibiting activity and antioxidant effect. Objective: In the present study, the effect of the flavonoid apigenin on diabetes-induced deteriorated vascular reactivity was investigated. Materials and methods:Insulin deficiency was induced by streptozotocin while, insulin resistance (IR) by fructose. Rats were left tenor twelve weeks after STZ or fructose administration respectively, isolated thoracic aorta reactivity to phenylephrine (PE), KCl, acetylcholine (ACh) and sodium nitroprusside (SNP) was studied. Results: Insulin deficiency increased responses to PE and KCl, decreased response to ACh but not affect response to SNP, while incubation with apigenin (7µM, 20min) normalized responses to PE, KCl andACh. In addition, insulin resistance (IR) increased responses to PE and KCl, decreased response to ACh but not affect the response to SNP, while in vitro incubation with apigenin normalized responses to PE, KCl and ACh. Furthermore, , protein kinase C stimulation by incubation with phorbol 12-myristate 13-acetate (PMA, 800nM, 1h) led to a similar impairment in isolated normal aorta to that seen in case of insulin deficiency and insulin resistance while co-incubation with apigenin restored normal vascular reactivity. Discussion and conclusion: Apigenin, a natural protein kinase C inhibitor, restores normal vascular reactivity in diabetes via a mechanism involving PKC inhibition.
INTRODUCTION
iabetes is a disorder caused by insulin deficiency or resistance. Insulin resistance is a component of glucose intolerance [1] , which is compensated by prolonged hyperinsulinemia. Eventually, pancreatic β-cells fail to secrete sufficient insulin, leading to non-insulin-dependent diabetes mellitus [2] .
In spite of the significant developments in antidiabetic therapy, diabetic complications continue to be seriously deleterious. Various types of diabetic complications affecting different systems in the body have been reported. The clinical course of the disease is largely determined by those complications. This is why prevention or treatment of the disabling complications associated with diabetes is very important [3] . Many of the clinical complications of diabetes may be ascribed to alterations in vascular structure and function, with subsequent end-organ damage and death [4] . Therefore, preventing vascular complications in diabetes can save diabetic patient from other complications.
Flavonoids are diphenylpropanoids that occur far and wide in plant foods and form important constituents of human diet. Apigenin is a 4′,5,7 trihydroxy flavone, belongs to a less toxic and nonmutagenic [5] flavone subclass of flavonoids. It is ubiquitously distributed in leaves, vegetables, stems and fruits of several vascular plants. It has been shown to act as a potent antioxidant [6] , protein kinase C inhibitor [6] [7] [8] . Apigenin is a flavone rich in the Chinese herb FlosChrysanthemi and many other plants. It has a variety of pharmacological activities, including hypotensive [9] , It has been reported that extract of FlosChrysanthemi caused vasodilatation in rat thoracic aorta [10] . However, the effects of apigenin on aortaeisolated from diabetic animals have not been clarified in isolated vascular preparations.
Therefore, the aim of the present work was to examine the effect of apigenin on diabetes-induced deteriorated vascular reactivity and illustrate its mechanism of action.
METHODS

Animals
Adult male Wistar albino rats with starting weight of 140-160 g for the insulin deficiency part and 90-110 g for insulin resistance part (Zagazig University, Zagazig, Egypt) were housed in standard polypropylene cages (five rats per cage) and kept on a light-dark cycle of equal duration, The incubation concentration and time of apigenin was chosen based upon that was previously reported [11] which was shown to significantly inhibit protein kinase C.
2.3Vascular reactivity
The vascular reactivity to various vasoconstrictors and vasodilators was investigated as early described [12;13] . Thoracic aorta rings were suspended under 8 mN resting tension in individual 30 ml organ chambers containing KrebsHenseleit buffer at 37°C and aerated with 95% oxygen, 5% carbon dioxide. Ring tension was determined by use of an isometric force transducer (Biegestab K30, HugosachsElektronik, March, Germany). Force displacement was recorded with a PowerLab Data Interface Module connected to a PC running Chart software (v4.2, ADI Instruments, Chalgrove, Oxon, UK). Rings were equilibrated for 60 min during which time, the bath solution was changed every 30 min. Before beginning the experiment, vessel viability was assessed by exposing arteries to KCl (80 mM). This was repeated until stable responses were achieved (usually two exposures). For studying the vasoconstrictor responsiveness of aorta, cumulative concentrations of phenylephrine (PE, 10 -9 to 10 -5 M) or KCl (10 to 100 mM) were added to the organ bath and the response was recorded. For studying the vasodilator responsiveness of aorta, rings were first precontracted with submaximal concentrations of PE (10 -6 in case of control or 3x10 -7 in case of insulin deficient or resistant group). The cumulative concentrations of acetylcholine (ACh, 10 -9 to 10 -5 M) or sodium nitroprusside (SNP, 10 -9 to 10 -5 M) were then added to the organ bath and the response was recorded. The submaximal concentration of PE was chosen to give similar precontraction in all studied groups. For studying the effect of PMA and apigenin on vascular reactivity, PMA (800nM) and apigenin(7µM) were included in the organ bath during the 60 min equilibration period and during the addition of vasoactive agents.
Drugs and chemicals
The following drugs and chemicals were used: Fructose (El-Nasr Chemical Co., Cairo, Egypt); STZ, apigenin, PMA, ACh, PE, SNP (SigmaAldrich, Dorset, UK). Apigenin was dissolved in 0.5N NaOH and PMA was frist dissolved in DMSO and diluted 10 times in Krebs Henseleit buffer. ACh, PE and SNP were dissolved in distilled water.
Statistical analysis
All data are expressed as mean ± SEM. Statistical analysis was performed by the analysis of variance (ANOVA) followed by Newman-Keuls' post hoc test. The agonist maximum response (E max ) was calculated from concentration-response curve by non-linear regression analysis of the curve using computer based fitting program and used for comparison (Prism 5, Graphpad, CA, USA).
3. RESULTS 3.1. Blood glucose, insulin and pressure Intra-peritoneal administration of STZ in a dose of 50 mg kg -1 led to a significant elevation in blood glucose (p<0.05) and a significant decrease in serum insulin (p<0.001) compared to control values. The STZ-induced insulin deficient rats had a significantly elevated systolic (p < 0.001) and diastolic BP (p< 0.001) compared to control (table  1) . Addition of fructose to the drinking water in concentration of 10% for 12 weeks led to a significant elevation in blood glucose (p<0.001) and serum insulin (p < 0.001) compared to control values. The fructose-induced insulin resistant rats had a significantly elevated systolic (p < 0.001) and diastolic BP (p < 0.001) compared to control (table  2) . 3.2 Vascular reactivity Cumulative addition of PE (PE, 10 -9 to 10 -5 M) or KCl (10 -2 to 10 -1 M) to the organ bath resulted in concentration dependent contraction of aorta in all the groups. Insulin deficiency induced by STZ resulted in anincrease in aorta responsiveness to PE, reflected by a significant increase in the apparent E max (p < 0. 001, Fig. 1a and table 3 ) and to KCl, reflected by a significant increase in the apparent E max (p < 0.001, Fig. 1b and table 3) .Apigenin (AP, 7µM, 1h) incubation prevented the insulin deficiency-induced hyper responsiveness to PE, reflected by a significant increase in apparent E max (p<0.001, Fig. 1a and table 3 )and the hyperresponsiveness to KCl, reflected by a significant increase in apparent E max (p<0.001, Fig. 1b and table  3 ). Cumulative addition of ACh (10 -9 to 10 -5 M) to the organ bath resulted in concentration-related decreases in the tension of aortic artery rings precontracted with phenylephrine. Insulin deficiency led to a large decrease in aorta responsiveness to ACh, reflected by a significant decrease in apparent E max (p < 0.001, Fig. 1c and  table 3 ). AP protected against insulin deficiencyinduced ACh hypo-responsiveness,reflected by a significant decrease in apparent E max compared with insulin deficient group (p<0.001, Fig. 1c and table  3 ). However, neither insulin deficiency nor AP treatment affect isolated aorta responsiveness to SNP (Fig. 1d and table 3 ). The insulin resistance rats showed a large increase in aorta responsiveness to both PE, reflected by a significant increase in apparent E max (p < 0.001, Fig.  2a and table 4 ) and to KCl, reflected by a significant increase in apparent E max (p < 0.001, Fig. 2b and  table 4 ).While, AP incubation significantly inhibited it the insulin resistance-induced hyper responsiveness to PE and to KCl (both at p<0.001, Fig. 2a&b, table 4 ). On the other hand, insulin resistance led to a decrease in aorta responsiveness to ACh, reflected by a significant decrease in apparent E max (p<0.001, Fig. 2c, table 4) .AP incubation prevented the insulin resistance-induced ACh hypo-responsiveness(p<0.001, Fig. 2c, table  4) . However, neither insulin resistance nor AP treatment affect isolated aorta responsiveness to SNP (Fig. 2d and table 4) .
Incubation of aorta with PMA (800nM, 1h) or AP (7µM, 1h) had no effect on the basal tension. In contrast, incubation with PMA (800nM, 1h) resulted in a large increase in aorta responsiveness to PE and KCl, reflected by a significant increase in apparent E max (both at P < 0.001, Fig 3a and 3b, table  5 )However, incubation with AP (7µM, 1h) protected against PMA-induced hyperresponsiveness to PE or KCl(both at p<0.001, Fig 3a and 3b, table 5 ). PMA and apigenin incubation led to no significant change in aorta responsiveness to ACh, (data not shown). AP incubation did not change aorta responsiveness to any of the used vasoactive agents compared to control (Fig 1-3, tables 3-5) .
4. DISCUSSION The purpose of this study was to investigate the effect of apigenin against diabetes-induced deterioration in vascular reactivity. We have shown for the first time that acute in vitro incubation with apigenin restored normal vascular reactivity in thoracic aorta isolated from either insulin deficient or insulin resistance animals. In addition, acute in vitro incubation with apigenin protected from exaggerated vasoconstriction responses induced by PKC stimulation. These findings suggest a novel biological activity for the well tolerated natural flavonoid, apigenin in the management of diabetic vascular complications.
As, diabetes is a disorder caused by insulin deficiency or resistance which are completely distinguished in characters, we investigated apigenin effect in two well established models of diabetes. In streptozotocin (STZ) model, single dose of STZ (50 mg.kg -1 , ip) developed significant hyperglycemia but hypoinsulinemia in 8 weeks. streptozotocin has been widely used to induce insulin deficiency through pancreatic β-cell destruction [14] . In the fructose model, including fructose (10%) in drinking water developed significant hyperinsulinemia and mild hyperglycemia in 12weeks. This appeared to be most suitable for production of fructose-induced insulin resistance [15] . In this study, insulin deficiency was associated with deterioration in vascular reactivity. We have found significant increases in aorta responsiveness to PE and to KCl and a large decrease in aorta responsiveness to ACh. However, insulin deficiency did not affect isolated aorta responsiveness to SNP.
Hyperglycemia due to insulin deficiency has been reported to cause vascular abnormalities, such as increase in the response to vasoconstrictor agents [16;17] and an impairment of endotheliumdependent vasodilatation [18] .In the insulin resistance model, we have reported an increased contraction of aorta to both PE and to KCl and a decrease in aorta responsiveness to ACh. However, insulin resistance did not affect isolated aorta responsiveness to SNP. There is an increasing evidence that, insulin resistance has adverse effects on the reactivity of arteries and arterioles and promotes arterial hypertension and vascular occlusive diseases [2] . Thoracic aorta from fructosefed rats showed exaggerated responses to PE and KCl [19;20] while several studies have shown that fructose-fed rats exhibit impaired endotheliumdependent relaxation in response to ACh [21] . Similar findings concerning impairment of endothelium-dependent dilation in insulin resistance people have been derived from several regional circulations [22] .The observed exaggerated vasoconstriction response could be due to increased extracellular calcium influx [16] . Instead, contractile responses can be modulated by agonists independently of changes in intracellular Ca 2+ through inhibition of myosin light chain phosphatase activity due to protein kinase C (PKC) activation, a process known as Ca 2+ sensitization [23;24] . On the other hand, the impairment in endothelial dependent relaxation could be through inhibition of NO generation. We have shown previously impairment in pulmonary artery endothelial dependent relaxation which was mediated by stimulation of reactive oxygen species (ROS) generation and nitric oxide synthase uncoupling [25] . The present study shows that 20 min in vitro incubation with apigenin (7µM) was able to restore normal vascular reactivity in aorta isolated from both insulin deficient or resistant animals. As, apigenin significantly inhibited the hyperresponsiveness to both PE and KCl while protected from ACh hypo-responsiveness in aorta isolated from both insulin deficient and resistant animals. The direct effect of apigenin on exaggerated vascular contractility associated with diabetes is seems to be mediated at least in part by PKC inhibition as apigenin is used in this study at the concentration it was reported to inhibit PKC [11] . In support of this hypothesis, we have found that incubation with PMA (800nM, 1h) resulted in a similar increase in aorta responsiveness to PE and KCl to that seen in insulin deficiency or resistance. However, incubation with apigenin protected against PMA-induced hyperresponsiveness to PE or KCl. On the other hand, the effect of apigenin on impaired vasodilatation in diabetes is likely mediated by its antioxidant effect. Apigenin is a well-known potent antioxidant [6] . Suppression of ROS by apigenin saves NO from quenching and hence restores normal vascular dilatation.
In conclusion, apigenin restored normal vascular reactivity in thoracic aorta isolated from either insulin deficient or insulin resistance animals by mechanisms involving protein kinase C inhibition.
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